Literature DB >> 19332059

Prion protein on astrocytes or in extracellular fluid impedes neurodegeneration induced by truncated prion protein.

Brent Race1, Kimberly Meade-White, Richard Race, Frank Baumann, Adriano Aguzzi, Bruce Chesebro.   

Abstract

Prion protein (PrP) is a host-encoded membrane-anchored glycoprotein which is required for susceptibility to prion disease. PrP may also be important for normal brain functions such as hippocampal spatial memory. Previously transgenic mice expressing amino terminally truncated mouse PrP (Delta32-134) spontaneously developed a fatal disease associated with degeneration of cerebellar granular neurons as well as vacuolar degeneration of deep cerebellar and brain stem white matter. This disease could be prevented by co-expression of wild-type (WT) mouse PrP on neurons or oligodendroglia. In the present experiments we studied Delta32-134 PrP transgenic mice with WT PrP expression restricted to astroglia, an abundant CNS cell-type important for neuronal viability. Expression of WT PrP in astroglia was sufficient to rescue 50% of mice from disease and prolonged survival by 200 days in the other 50%. We also found that transgenic mice expressing full-length soluble anchorless PrP had increased survival by 100 days. Together these two results indicated that rescue from neurodegeneration induced by Delta32-134 PrP might involve interactions between neurons expressing truncated PrP and nearby astrocytes expressing WT PrP or extracellular fluid containing soluble WT PrP.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332059      PMCID: PMC2721470          DOI: 10.1016/j.expneurol.2009.03.017

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  30 in total

1.  Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice.

Authors:  John Curtis; Mick Errington; Tim Bliss; Karen Voss; Nikki MacLeod
Journal:  Neurobiol Dis       Date:  2003-06       Impact factor: 5.996

2.  N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

Authors:  B Caughey; G J Raymond; D Ernst; R E Race
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Evidence that the transmission of one source of scrapie agent to hamsters involves separation of agent strains from a mixture.

Authors:  R H Kimberlin; C A Walker
Journal:  J Gen Virol       Date:  1978-06       Impact factor: 3.891

4.  Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen.

Authors:  R Race; M Oldstone; B Chesebro
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Toxicity of novel C-terminal prion protein fragments and peptides harbouring disease-related C-terminal mutations.

Authors:  M Daniels; G M Cereghetti; D R Brown
Journal:  Eur J Biochem       Date:  2001-12

6.  Tumor necrosis factor attenuates prion protein-deficient neuronal cell death by increases in anti-apoptotic Bcl-2 family proteins.

Authors:  Akikazu Sakudo; Deug-Chan Lee; Keiichi Saeki; Yoshitsugu Matsumoto; Shigeyoshi Itohara; Takashi Onodera
Journal:  Biochem Biophys Res Commun       Date:  2003-10-24       Impact factor: 3.575

7.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

8.  Nearly ubiquitous tissue distribution of the scrapie agent precursor protein.

Authors:  P E Bendheim; H R Brown; R D Rudelli; L J Scala; N L Goller; G Y Wen; R J Kascsak; N R Cashman; D C Bolton
Journal:  Neurology       Date:  1992-01       Impact factor: 9.910

9.  Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration.

Authors:  G R Mallucci; S Ratté; E A Asante; J Linehan; I Gowland; J G R Jefferys; J Collinge
Journal:  EMBO J       Date:  2002-02-01       Impact factor: 11.598

10.  The CNS glycoprotein Shadoo has PrP(C)-like protective properties and displays reduced levels in prion infections.

Authors:  Joel C Watts; Bettina Drisaldi; Vivian Ng; Jing Yang; Bob Strome; Patrick Horne; Man-Sun Sy; Larry Yoong; Rebecca Young; Peter Mastrangelo; Catherine Bergeron; Paul E Fraser; George A Carlson; Howard T J Mount; Gerold Schmitt-Ulms; David Westaway
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

View more
  7 in total

1.  Increased excitatory amino acid transport into murine prion protein knockout astrocytes cultured in vitro.

Authors:  Melissa S Pathmajeyan; Sarjubhai A Patel; James A Carroll; Todd Seib; James F Striebel; Richard J Bridges; Bruce Chesebro
Journal:  Glia       Date:  2011-07-15       Impact factor: 7.452

Review 2.  Anchorless risk or released benefit? An updated view on the ADAM10-mediated shedding of the prion protein.

Authors:  Behnam Mohammadi; Feizhi Song; Andreu Matamoros-Angles; Mohsin Shafiq; Markus Damme; Berta Puig; Markus Glatzel; Hermann Clemens Altmeppen
Journal:  Cell Tissue Res       Date:  2022-01-27       Impact factor: 5.249

Review 3.  Deciphering therapeutic options for neurodegenerative diseases: insights from SIRT1.

Authors:  Ruike Wang; Yingying Wu; Rundong Liu; Mengchen Liu; Qiong Li; Yue Ba; Hui Huang
Journal:  J Mol Med (Berl)       Date:  2022-03-11       Impact factor: 4.599

Review 4.  Cellular prion protein: from physiology to pathology.

Authors:  Sei-ichi Yusa; José B Oliveira-Martins; Yoshiko Sugita-Konishi; Yutaka Kikuchi
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

5.  The toxicity of a mutant prion protein is cell-autonomous, and can be suppressed by wild-type prion protein on adjacent cells.

Authors:  Emiliano Biasini; Jessie A Turnbaugh; Tania Massignan; Pietro Veglianese; Gianluigi Forloni; Valentina Bonetto; Roberto Chiesa; David A Harris
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

6.  Structural and mechanistic aspects influencing the ADAM10-mediated shedding of the prion protein.

Authors:  Luise Linsenmeier; Behnam Mohammadi; Sebastian Wetzel; Berta Puig; Walker S Jackson; Alexander Hartmann; Keiji Uchiyama; Suehiro Sakaguchi; Kristina Endres; Jörg Tatzelt; Paul Saftig; Markus Glatzel; Hermann C Altmeppen
Journal:  Mol Neurodegener       Date:  2018-04-06       Impact factor: 14.195

Review 7.  Astrocyte in prion disease: a double-edged sword.

Authors:  Waqas Tahir; Simrika Thapa; Hermann M Schatzl
Journal:  Neural Regen Res       Date:  2022-08       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.